Merck Revenue 2006-2021 | MRK

Merck annual/quarterly revenue history and growth rate from 2006 to 2021. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
  • Merck revenue for the quarter ending June 30, 2021 was $11.402B, a 21.91% increase year-over-year.
  • Merck revenue for the twelve months ending June 30, 2021 was $50.066B, a 9.62% increase year-over-year.
  • Merck annual revenue for 2020 was $47.994B, a 2.46% increase from 2019.
  • Merck annual revenue for 2019 was $46.84B, a 10.75% increase from 2018.
  • Merck annual revenue for 2018 was $42.294B, a 5.41% increase from 2017.
Merck Annual Revenue
(Millions of US $)
2020 $47,994
2019 $46,840
2018 $42,294
2017 $40,122
2016 $39,807
2015 $39,498
2014 $42,237
2013 $44,033
2012 $47,267
2011 $48,047
2010 $45,987
2009 $27,428
2008 $23,850
2007 $24,198
2006 $22,636
2005 $22,012
Merck Quarterly Revenue
(Millions of US $)
2021-06-30 $11,402
2021-03-31 $12,080
2020-12-31 $14,033
2020-09-30 $12,551
2020-06-30 $9,353
2020-03-31 $12,057
2019-12-31 $11,867
2019-09-30 $12,397
2019-06-30 $11,760
2019-03-31 $10,816
2018-12-31 $10,998
2018-09-30 $10,794
2018-06-30 $10,465
2018-03-31 $10,037
2017-12-31 $10,433
2017-09-30 $10,325
2017-06-30 $9,930
2017-03-31 $9,434
2016-12-31 $10,115
2016-09-30 $10,536
2016-06-30 $9,844
2016-03-31 $9,312
2015-12-31 $10,215
2015-09-30 $10,073
2015-06-30 $9,785
2015-03-31 $9,425
2014-12-31 $10,482
2014-09-30 $10,557
2014-06-30 $10,934
2014-03-31 $10,264
2013-12-31 $11,320
2013-09-30 $11,032
2013-06-30 $11,010
2013-03-31 $10,671
2012-12-31 $11,737
2012-09-30 $11,488
2012-06-30 $12,311
2012-03-31 $11,731
2011-12-31 $12,294
2011-09-30 $12,022
2011-06-30 $12,151
2011-03-31 $11,580
2010-12-31 $12,094
2010-09-30 $11,125
2010-06-30 $11,346
2010-03-31 $11,422
2009-12-31 $10,093
2009-09-30 $6,050
2009-06-30 $5,900
2009-03-31 $5,385
2008-12-31 $6,032
2008-09-30 $5,944
2008-06-30 $6,052
2008-03-31 $5,822
2007-12-31 $6,243
2007-09-30 $6,074
2007-06-30 $6,111
2007-03-31 $5,769
2006-12-31 $6,044
2006-09-30 $5,410
2006-06-30 $5,772
2006-03-31 $5,410
2005-12-31 $5,766
2005-09-30 $5,416
2005-06-30 $5,468
2005-03-31 $5,362
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $205.421B $47.994B
Merck & Co., Inc., a leading global biopharmaceutical company known as MSD outside of the United States and Canada, has been inventing for life, bringing forward medicines and vaccines for many of the world's most challenging diseases. Through their prescription medicines, vaccines, biologic therapies and animal health products, they work with customers and operate the countries to deliver innovative health solutions. The Company also demonstrate their commitment to increasing access to health care through far-reaching policies, programs and partnerships. Merck continues to be at the forefront of research to advance the prevention and treatment of diseases that threaten people and communities around the world - including cancer, cardio-metabolic diseases, emerging animal diseases, Alzheimer's disease and infectious diseases including HIV and Ebola.
Stock Name Country Market Cap PE Ratio
Johnson & Johnson (JNJ) United States $430.990B 17.18
Novo Nordisk (NVO) Denmark $249.632B 34.64
Pfizer (PFE) United States $241.985B 13.75
Eli Lilly (LLY) United States $233.762B 30.35
AbbVie (ABBV) United States $192.870B 9.24
Novartis AG (NVS) Switzerland $189.944B 14.11
GlaxoSmithKline (GSK) United Kingdom $107.085B 13.44